Sildenafil Powder, For Suspension
Product Images NDC 27241-175

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 27241-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil 10mg Carton

Sildenafil for Oral Suspension 10 mg/mL powder for suspension carton from Ajanta Pharma USA Inc., containing 112 mL following reconstitution. The label states it is for oral use only, grape flavored, with directions to shake well before each use. Reconstitution instructions and storage recommendations are included on the packaging.*

FDA Label Image

Sildenafil 10mg

Label for Sildenafil for Oral Suspension, 10 mg/mL, powder for suspension by Ajanta Pharma USA Inc. Directions indicate the powder is to be reconstituted with 90 mL water to make 112 mL suspension. Label includes storage instructions, dosage caution, child-resistant package note, grape flavoring, and barcode.*

FDA Label Image

Sildenafil Figure3

An instructional diagram showing a medication vial alongside a graduated cylinder and a syringe marked with measurement units. The syringe is labeled with a quantity of 'x 1,' likely indicating a single dose or draw from the vial for suspension preparation or administration.*

FDA Label Image

Sildenafil_figure1 (Sildenafil Figure1)

An instructional illustration depicting a graduated cylinder filled with liquid, a bottle partially filled with liquid, and a dosing syringe marked with volume increments. This diagram likely shows how to measure and draw liquid medication from a bottle using a syringe for oral administration.*

FDA Label Image

Sildenafil_figure10.jpg (Sildenafil Figure10)

A clinical data chart showing placebo-corrected changes in 6-minute walk distance (meters) for patients treated with Sildenafil 20 mg three times daily compared to placebo. The graph categorizes data by baseline walk distance, etiology, functional class, gender, age, mean pulmonary arterial pressure (PAR), and pulmonary vascular resistance index (PVRI). The plot includes data points with confidence intervals for each subgroup, illustrating the comparative effectiveness of Sildenafil versus placebo.*

FDA Label Image

Sildenafil_figure11 (Sildenafil Figure11)

A line graph comparing the percentage of patients without a clinically worsening event over time between placebo and sildenafil groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage (0 to 100). Two lines illustrate the clinical outcomes for placebo and sildenafil groups.*

FDA Label Image

Sildenafil_figure12 (Sildenafil Figure12)

A line plot illustrating the mean change from baseline in a measured parameter over 12 weeks in a study of Sildenafil oral administration at doses of 1 mg TID, 5 mg TID, and 20 mg TID. Data points at weeks 4, 8, and 12 include standard error bars for each treatment group.*

FDA Label Image

Sildenafil_figure2 (Sildenafil Figure2)

Instructional illustration showing how to prepare a suspension from a bottle. The steps include pressing and twisting the cap to open, shaking the bottle up and down, and timing with a stopwatch, likely indicating the recommended shaking duration before use.*

FDA Label Image

Sildenafil_figure4 (Sildenafil Figure4)

An instructional illustration showing three steps to prepare an oral suspension bottle: pressing and turning the cap to open, shaking the bottle up and down to mix, and using a stopwatch to time the process.*

FDA Label Image

Sildenafil_figure5 (Sildenafil Figure5)

An instructional illustration showing the steps to open and close a bottle. The left image shows a hand pressing down to remove a cap from a bottle, and the right image shows a hand pressing down and twisting the cap clockwise to close the bottle. Both images feature a bottle with liquid inside and arrows indicating the direction of actions.*

FDA Label Image

Sildenafil_figure6 (Sildenafil Figure6)

A line graph depicting estimated cumulative mortality rate (%) over time (years) for three different dose groups: High Dose, Medium Dose, and Low Dose. The graph shows increasing mortality rates over 5 years with High Dose having the highest rate, Medium Dose intermediate, and Low Dose the lowest. Numbers at risk are shown decreasing over time for each group.*

FDA Label Image

Sildenafil_figure7 (Sildenafil Figure7)

A horizontal bar chart showing drug interaction effects of various interacting drugs on Sildenafil pharmacokinetics with fold change and 90% confidence intervals. The x-axis represents change relative to Sildenafil alone. Drugs include Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. Recommendations regarding dose adjustments and coadministration are noted.*

FDA Label Image

Sildenafil_figure8 (Sildenafil Figure8)

A forest plot chart showing fold change and 90% confidence intervals for various drug interactions with sildenafil. The chart includes drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Recommendations on dose adjustments, mostly indicating no dose adjustment needed, are listed alongside each drug. The graph's x-axis represents change relative to interacting drug alone, with a vertical line at 1.*

FDA Label Image

Sildenafil_figure9.jpg (Sildenafil Figure9)

A scatter plot showing change from baseline in patients over weeks 4, 8, and 12 of a study. Data points with error bars represent sildenafil doses 40 mg TID and 80 mg TID compared to placebo. The vertical axis measures change from baseline (patients), and the horizontal axis represents weeks in the study.*

FDA Label Image

Figurea (Sildenafil Figurea)

An instructional diagram showing components of Sildenafil oral suspension packaging and dosing device. It illustrates a bottle of Sildenafil for oral suspension with a cap and syringe adaptor, alongside a dosing syringe labeled with tip, barrel, plunger, and volume markings up to 3.5 mL.*

FDA Label Image

Figureb (Sildenafil Figureb)

An instructional illustration showing how to properly shake a vial or bottle and remove the cap. The left part demonstrates the shaking motion with arrows around the bottle. The center shows a stopwatch indicating timing. The right part illustrates the hand pulling the cap upward and then rotating it to open the bottle.*

FDA Label Image

Figurec (Sildenafil Figurec)

An instructional illustration labeled Figure C showing a hand holding a bottle while another hand inserts a marked syringe or measuring device into the bottle. The device appears to be used for measuring or withdrawing liquid from the bottle, likely related to the preparation or dosing of the oral suspension.*

FDA Label Image

Figured (Sildenafil Figured)

An instructional illustration labeled Figure D shows a hand holding an upside-down bottle with liquid, and a syringe positioned below it to draw the liquid. The image depicts the process of withdrawing medication from a bottle using a syringe.*

FDA Label Image

Figuree (Sildenafil Figuree)

An instructional illustration labeled Figure E shows a syringe being inserted into the neck of a bottle, with an upward arrow indicating the direction to pull the syringe plunger, suggesting the drawing of liquid from the bottle.*

FDA Label Image

Figuref (Sildenafil Figuref)

An instructional line drawing labeled Figure F showing the side profile of a person's nose and mouth with a syringe approaching the open mouth, likely illustrating oral administration technique.*

FDA Label Image

Figureg (Sildenafil Figureg)

An instructional diagram labeled Figure G showing water flowing from a faucet into three syringes held horizontally, demonstrating a method for filling or rinsing the syringes.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of the active ingredient Sildenafil. The diagram shows the molecular arrangement and connectivity of atoms making up Sildenafil, consistent with its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.